Triple Negative Breast Cancer Market Trends: Innovation, Commercial Shifts, and Growth Prospects
Triple negative breast cancer remains one of the most clinically challenging and commercially significant segments within the global breast cancer market. Defined by the lack of estrogen receptors, progesterone receptors, and HER2 expression, TNBC has long been associated with limited targeted treatment options and unfavorable outcomes compared with other breast cancer subtypes. Yet the...
0 Yorumlar 0 hisse senetleri 29 Views 0 önizleme